Show simple item record

dc.contributor.authorMendez, Maria A.
dc.contributor.authorOakley, Bethany
dc.contributor.authorCanitano, Roberto
dc.contributor.authorTinelli, Michela
dc.contributor.authorKnapp, Martin
dc.contributor.authorCusack, James
dc.contributor.authorParellada, Mara
dc.contributor.authorViolland, Pierre
dc.contributor.authorDerk Plas, Jan R.
dc.contributor.authorMurphy, Declan G.M.
dc.contributor.authorQuoidbach, Vinciane
dc.contributor.authorArango, Celso
dc.contributor.authorSan Jose Cáceres, Antonia
dc.contributor.authorCanal Bedia, Ricardo 
dc.contributor.authorBejarano Martín, Álvaro 
dc.contributor.authorarango
dc.date.accessioned2026-01-15T10:43:23Z
dc.date.available2026-01-15T10:43:23Z
dc.date.issued2023-09-11
dc.identifier.citationMendez, Maria A., et al. «Autism Care Pathway in Europe». European Psychiatry, vol. 66, n.o 1, 2023, p. e81. DOI.org (Crossref), https://doi.org/10.1192/j.eurpsy.2023.2435.es_ES
dc.identifier.issn0924-9338
dc.identifier.urihttp://hdl.handle.net/10366/168819
dc.description.abstract[EN] Background. Autism is a lifelong complex neurodevelopmental condition that affects brain development and behaviour with significant consequences for everyday life. Despite its personal, familial, and societal impact, Europe-wide harmonised guidelines are still lacking for early detection, diagnosis, and intervention, leading to an overall unsatisfactory autistic person and carer journey. Methods. The care pathway for autistic children and adolescents was analysed in Italy, Spain and the UK from the perspective of carers (using a survey aimed at caregivers of autistic children 0–18 years old), the autistic community, and professionals in order to identify major barriers (treatment gaps) preventing carers from receiving information, support, and timely screening/ diagnosis and intervention. Results. Across all three countries, analysis of the current care pathway showed: long waits from the time carers raised their first concerns about a child’s development and/or behaviour until screening and confirmed diagnosis; delayed or no access to intervention once a diagnosis was confirmed; limited information about autism and how to access early detection services; and deficient support for families throughout the journey. Conclusions. These findings call for policy harmonisation in Europe to shorten long wait times for diagnosis and intervention and therefore, improve autistic people and their families’ journey experience and quality of life.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherCambridge University Presses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAutismes_ES
dc.subjectDiagnosises_ES
dc.subjectEarly interventiones_ES
dc.subjectEarly screeninges_ES
dc.subjectPolicy recommendationses_ES
dc.subject.meshDiagnosis *
dc.subject.meshAutistic Disorder *
dc.titleAutism care pathway in Europees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1192/j.eurpsy.2023.2435es_ES
dc.subject.unesco61 Psicologíaes_ES
dc.subject.unesco3212 Salud Publicaes_ES
dc.subject.unesco6105 Evaluación y Diagnostico en Psicologíaes_ES
dc.identifier.doi10.1192/J.EURPSY.2023.2435
dc.relation.projectIDH2020-JTI-IMI2-777394-2es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1778-3585
dc.journal.titleEuropean Psychiatryes_ES
dc.volume.number66es_ES
dc.issue.number1es_ES
dc.page.initial1es_ES
dc.page.final10es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decstrastorno autístico *
dc.subject.decsdiagnóstico *
dc.description.projectEU/EFPIA/ SFARI/Autistica/AUTISM SPEAKS Innovative Medicines Initiative 2 Joint Undertaking (AIMS-2-TRIALS grant n° 777394)es_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional